
Publication|Videos|May 13, 2024
Talking Strategic Development with Simtra at DCAT
Author(s)Simtra BioPharma Solutions
Ray Guidotti, Chief Operating Officer at Simtra BioPharma Solutions, talks about the company's strategic development and how it supports customers with a focus on excellence.
Simtra BioPharma Solutions is a premier contract development and manufacturing organization (CDMO) with more than 65 years of sterile injectable (SI) experience and a dedicated focus on providing a range of services from clinical development to commercial fill/finish. Learn more about:
- Simtra’s new building in Halle that features a high-speed syringe line and vial line equipped with four lyophilizers and is expected to be GMP ready in 2024.
- The new clinical line in Bloomington that will be ready to take on projects in the summer of 2025.
- Construction of the new state-of-the-art building in Bloomington that will begin in the summer of 2024.
Trending on Pharmaceutical Technology
1
H1 2026 in Review: AI Adoption, Onshoring, and Data Gaps
2
What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development
3
Is Organizational Readiness Pharma's Real AI Barrier in 2026?
4
Regulatory Roundup—July 2026
5




